Researcher Profile Form First National Pediatric Brain Tumor Research Meeting March 9, 2025 - Jerusalem
Researcher: Dr. Shlomit Kenigsberg
Basic Info
Title/Position: Scientific Advisor
Institution: Chief Scientific Office
Email: shlomit.kenig@gmail.com
Phone: 050-2057665
Current Role & Affiliation
Experienced scientist with a broad knowledge of Extracellular Vesicles (exosomes), liquid biopsy and biobanking.Dr Kenigsberg is currently serving as the National Coordinator for Horizon Europe Research and Innovation at the Chief Scientist Office -ECRIN (European Clinical Research Infrastructure Network).Dr Kenigsberg served as the VP for strategy and growth of Nextar chemopharma biotech company.
Current Projects Related to Pediatric Brain Tumors
Nextar Chempharma Solutions Ltd.developed a proprietary universal Brain-Trasported Liposomes (BTLs) platform, which can facilitate targeted delivery of generic and innovative drugs across the blood-brain-barrier (BBB) into the brain. Its 1st indication if a drug for Glioblastoma
What You Can Offer Potential Collaborators
Extensive experience in research
Experience and interest in collaborations with multiple governmental and international players
Keywords
Exosomes,Next Generation Sequencing,microRNA, Translational Research, biotech,
Recent Relevant Publications
1. Kenigsberg S, et.al. Protocol for Exosome Isolation from Small Volume of Ovarian Follicular Fluid: Evaluation of Ultracentrifugation and Commercial Kits. Methods Mol Biol. 2017;1660:321-341.
2. Kenigsberg S,et.al. The elusive MAESTRO gene: Its human reproductive tissue-specific expression pattern. PLoS One. 2017 Apr 13;12(4):e0174873.
Brief Bio
Shlomit Kenigsberg, Holding a Ph.D. in Epigenetics and an MBA in Clinical Leadership, is a multidisciplinary leader in health research, innovation, and therapeutic transformation, currently serving as the National Coordinator at ERA4Health (Health Research) and EPPerMed (Personalized medicine) under the Chief Scientist’s Office at the Israeli Ministry of Health. With over 25 years in IVF and human reproduction, she led ovarian research, established the first IVF-related Biobank, and pioneered exosome studies. She has held key roles in biotech business development at NIBN, VP of Growth and Strategy at Nextar Chempharma, leading the Brain-Targeted Liposomes (BTLs) platform for glioblastoma, and co-founding the Exosomes Society.
